New Drug Promising for Resistant Focal Epilepsy
A novel investigational antiseizure medication reduces seizure frequency by more than 50% in some patients with treatment-resistant focal epilepsy.
Stay updated with breaking news from Epilepsy Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A novel investigational antiseizure medication reduces seizure frequency by more than 50% in some patients with treatment-resistant focal epilepsy.
A husband-wife science duo is putting their brains together to study other brains.
Andrew N. Wilner, MD, and Jacqueline French, MD, discuss the diagnosis of epilepsy and the use of remote adjudication of patients in clinical trials.
The new eDiary solution optimizes data quality and simplifies epilepsy trial participation PHILADELPHIA, Jan. 17, 2023 /PRNewswire/ -- Signant Health, the leader in evidence generation
/PRNewswire/ -- Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Jacqueline French, MD, as a...